Featured news

• 

  17/04/24

  Inaugural All-Partners Meeting at Chulalongkorn Sets the Bar High

  It was an incredibly successful gathering where collaboration and innovation took centre stage. Grateful to all who participated and contributed to this milestone moment.

• 

  20/03/24

  The Hub Receives Visit from the Foreign Secretary

  The UK-South East Asia Vaccine Manufacturing Research Hub was among the highlighted projects during the recent visit of the Foreign Secretary to Thailand.

  read more
• 

  16/02/24

  The Hub Extends a Warm Welcome to Rachel Park as Advisor

  Rachel Park serves as the Director for International Business at EuBiologics (South Korea) and holds a position on the board of the Developing Countries Vaccine Manufacturing Network (DCVMN).

• 31/01/24

  Dr. Zoltan Kis Secures New Funding!

  Teaming up with Amodo Design, the Sheffield team, under Dr. Zoltan Kis's leadership, is set to design and build RNAboxTM—a state-of-the-art fully-automated compact RNA manufacturing process.

  read more
• 29/01/24

  Esteemed Appointment to Advisory Board: Prof. Drew Weissman

  Renowned for his groundbreaking work in nucleoside base modifications leading to the development of effective mRNA vaccines against COVID-19, Prof. Drew Weissman, the recipient of the 2023 Nobel Prize in Physiology or Medicine, will now contribute his expertise to the advisory board of the UK-SEA Vax Hub.

• 18/01/24

  Exciting Opportunity: Six Fully-Funded PhD Positions Available!

  The UK-SEA Vax Hub is thrilled to announce the offering of six fully-funded PhD positions. These positions encompass both computational and experimental projects within the field of vaccine manufacturing. Apply now!

  read more
• 16/01/24

  The Hub Extends a Warm Welcome to Dr. Martin Friede as Advisor

  Dr. Martin Friede, instrumental in facilitating the mRNA vaccine technology transfer hub in South Africa under the World Health Organization (WHO), has accepted a position on the advisory board of the UK-SEA Vax Hub.

• 10/01/24

  Major Indonesian Vaccine Manufacturer Joins Forces with UK-SEA Vax Hub

  Biofarma, the leading vaccine manufacturer in Indonesia and a recipient of mRNA vaccine technology transfer, has officially become a member of the UK-SEA Vax Hub.

• 01/01/24

  New Funding Secured!

  Prof. Tuck Seng Wong, Dr. Kang Lan Tee, and Prof. Kiat Ruxrungtham have secured funding from the International Science Partnership Fund (ISPF) Institutional Support Grant, administered by Research England. The grant will support the development of antigen and VLP banks, alongside the development of an mRNA-based HPV therapeutic vaccine.

• 03/11/23

  Enhancing Vaccine Accessibility in Low- and Middle-Income Countries

  UK Research and Innovation (UKRI) has allocated investments to four vaccine manufacturing research hubs, including the UK-SEA Vax Hub. This initiative aims to tackle the challenges associated with vaccine manufacturing and distribution in developing nations.

  read more
• 03/11/23

  Strengthening Ties: South East Asia and UK Partnership Flourishes

  Minister Will Quince officially introduced the UK-SEA Vax Hub during a dinner reception, marking the welcoming of Secretary-General of ASEAN Dr. Kao Kim Hourn on his first UK visit.

  read more
• 03/11/23

  Sheffield to Spearhead £7.6M UK-SEA Vax Hub!

  Prof. Tuck Seng Wong and Prof. Kiat Ruxrungtham will lead the new vaccine manufacturing research hub. This initiative is jointly funded by the Department of Health and Social Care (DHSC) and the Engineering and Physical Sciences Research Council (EPSRC).

  read more